Green Thumb Industries (GTBIF) Common Equity (2018 - 2026)
Green Thumb Industries' (GTBIF) quarterly Common Equity came in at $1.9 billion in Q1 2026, up 4.8% YoY from $1.8 billion in Q1 2025, and down 0.92% on a QoQ basis from $1.9 billion in Q4 2025.
Green Thumb Industries (GTBIF) Common Equity (2018 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 9 years of Common Equity data on file, last reported at $1.9 billion in Q1 2026.
- Quarterly Common Equity rose 4.8% year-over-year to $1.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 billion (up 4.8% YoY) and the FY2025 annual result came in at $1.9 billion, up 6.79% from the prior year.
- Common Equity retreated to $1.9 billion in Q1 2026, from $1.9 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.9 billion in Q4 2025 to a low of $1.7 billion in Q1 2022.
- A 5-year average of $1.8 billion and a median of $1.7 billion in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity soared 50.07% — and 2023, when it advanced 0.01%.
- Tracing GTBIF's Common Equity over 5 years: stood at $1.7 billion in 2022, then climbed by 2.27% to $1.7 billion in 2023, then increased by 5.04% to $1.8 billion in 2024, then gained by 6.79% to $1.9 billion in 2025, then retreated by 0.92% to $1.9 billion in 2026.
- The last three Common Equity figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 1.86 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Bn |
| Mar 31, 2026 | 1.89 Bn |
| Dec 31, 2025 | 1.91 Bn |
| Sep 30, 2025 | 1.83 Bn |
| Jun 30, 2025 | 1.80 Bn |
| Mar 31, 2025 | 1.81 Bn |
| Dec 31, 2024 | 1.79 Bn |
| Sep 30, 2024 | 1.77 Bn |
| Jun 30, 2024 | 1.75 Bn |
| Mar 31, 2024 | 1.75 Bn |
| Dec 31, 2023 | 1.70 Bn |
| Sep 30, 2023 | 1.71 Bn |
| Jun 30, 2023 | 1.71 Bn |
| Mar 31, 2023 | 1.68 Bn |
| Dec 31, 2022 | 1.67 Bn |
| Sep 30, 2022 | 1.71 Bn |
| Jun 30, 2022 | 1.69 Bn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | 1.62 Bn |
| Sep 30, 2021 | 1.45 Bn |